The burden of treatment: Listening to stories of adolescents with ADHD about stimulant medication use

Ethical Human Psychology and Psychiatry

Volumn 16, Issue 1, 2014, Pages 37-50

  Avisar, Alon ^a   Lavie Ajayi, Maya ^b  

^a Department of Educational Psychology Services ^*  (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Adolescents; Attention deficit hyperactivity disorder; Methylphenidate; Stimulant medications; Treatment

Indexed keywords

CENTRAL STIMULANT AGENT; METHYLPHENIDATE;

ADOLESCENT; AGGRESSION; ARTICLE; ATTENTION DEFICIT DISORDER; DECISION MAKING; DEPRESSION; FEMALE; HIGH SCHOOL; HUMAN; HUMAN RELATION; IDENTITY; INTELLIGENCE; LOSS OF APPETITE; MALE; MOTIVATION; PATIENT COMPLIANCE; PERSONAL EXPERIENCE; PHARMACEUTICAL CARE; PRESCRIPTION; PRIMARY SCHOOL; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; RECOGNITION; SEMI STRUCTURED INTERVIEW; SIDE EFFECT; SOCIAL INTERACTION; SOCIAL LIFE; SOCIAL PROBLEM;

EID: 84944036600     PISSN: 15594343     EISSN: 19389000     Source Type: Journal    
DOI: 10.1891/1559-4343.16.1.37     Document Type: Article

References (41)

1. American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). Washington, DC: Author.
2. Barkley, R. A. (2004). Adolescents with attention-deficit/hyperactivity disorder: An overview of empirically based treatments. Journal of Psychiatric Practice, 10, 39-56.
3. Buitelaar, J., & Medori, R. (2010). Treating attention-deficit/hyperactivity disorder beyond symptom control alone in children and adolescents: A review of the potential benefits of long-acting stimulants. European Child & Adolescent Psychiatry, 19, 325-340.
4. Bussing, R., Koro-Ljungberg, M., Noguchi, K., Mason, D., Mayerson, G., & Garvan, C. W. (2012). Willingness to use ADHD treatments: A mixed methods study of perceptions by adolescents, parents, health professionals and teachers. Social Science & Medicine, 74, 92-100.
5. Bussing, R., Zima, B. T., Mason, D. M., Porter, P. C., & Garvan C. W. (2011). Receiving treatment for attention deficit/hyperactivity disorder: Do adolescents' perspectives matter? Journal of Adolescent Health, 49, 7-14.
6. Coghill, D. (2010).The impact of medications on quality of life in attention-deficit hyperactivity disorder: A systematic review. CNS Drugs, 24(10), 843-866.
7. Danckaerts, M., Sonuga-Barke, E. J., Banaschewski, T., Buitelaar, J., Döpfner, M., Hollis, C., Coghill, D. (2010). The quality of life of children with attention deficit/hyperactivity disorder: A systematic review. European Child & Adolescent Psychiatry, 19(2), 83-105.
8. Efron, D., Jarman, F. C., & Barker, M. (1998). Child and parent perceptions of stimulant medication treatment in attention deficit hyperactivity disorder. Journal of Pediatrics and Child Health, 34, 288-292.
9. Evans, S. W., & Pelham, W. E. (2001). Psycho-stimulant effects on academic and behavioral measures for ADHD junior high school students in a lecture format classroom. Journal of Abnormal Child Psychology, 19, 537-552.
10. Fischer, M., Barkley, R. A., & Fletcher, K. E. (1993). The adolescent outcome of hyperactive children: Predictors of psychiatric, academic, social, and emotional adjustment. Journal of the American Academy of Child and Adolescent Psychiatry, 32, 324-332.
11. Flapper, B. C., & Schoemaker, M. M. (2008). Effects of methylphenidate on quality of life in children with both developmental coordination disorder and ADHD. Developmental Medicine & Child Neurology, 50(4), 294-299.
12. Fulton, B. D., Scheffler, R. M., Hinshaw, S. P., Levine, P., Stone, S., Brown, T. T., Modrek, S. (2009). National variation of ADHD diagnostic prevalence and medication use: Health care providers and education policies. Psychiatry Services, 60, 1075-1083.
13. Gittelman, R., Klein, D. F., & Feingold, I. (1983). Children with reading disorders-II. Effects of methylphenidate in combination with reading disabilities. Journal of Child Psychology and Psychiatry, 24, 193-212.
14. Goldman, L. S., Genel, M., Bezman, R. J., & Slantez, P. J. (1998). Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Journal of the American Medical Association, 279, 1100-1107.
15. Harpur, R. A., Thompson, M., Daley, D., Abikoff, H., & Sonuga-Barke, E. J. S. (2008). The attention-deficit/hyperactivity disorder medication-related attitudes of patients and their parents. Journal of Child and Adolescent Psychopharmacology, 18, 461-473.
16. Hazell, P. (2007). Pharmacological management of attention-deficit hyperactivity disorder in adolescents-Special considerations. CNS Drugs, 21, 37-46.
17. Hechtman, L. (2004). Long-term stimulant effects in children with attention deficit hyperactivity disorder (ADHD). Child & Adolescent Psychopharmacology News, 9, 1-6.
18. Holden, S., Jenkins-Jones, S., Poole, D. C., Morgan, C., Coghill, D., & Currie, C. J. (2013). The prevalence and incidence, resource use and financial costs of treating people with attention deficit/hyperactivity disorder (ADHD) in the United Kingdom (1998 to 2010). Child and Adolescent Psychiatry and Mental Health, 7, 20-34.
19. Lavie, M., & Willig, C. (2005) "I don't feel like melting butter": An interpretative phenomenological analysis of the experience of "inorgasmia". Psychology and Health, 20(1), 115-128.
20. Leslie, L. K., Plemmons, D., Monn, A. R., & Palinkas, L. A. (2007). Investigating ADHD treatment trajectories: Listening to families' stories about medication use. Journal of Developmental & Behavioral Pediatrics, 28, 179-188.
21. Leslie, L. K., & Wolraich, M. L. (2007). ADHD service use patterns in youth. Journal of Pediatric Psychology, 32, 695-710.
22. Manos, M., Frazier, T. W., & Landgraf, J. M. (2009). HRQL and medication satisfaction in children with ADHD treated with the methylphenidate transdermal system. Current Medical Research and Opinion, 25(12), 3001-3010.
23. Marcus, S., Wan, G., Kemner, J., & Olfson, M. (2005). Continuity of methylphenidate treatment for attention deficit/hyperactivity disorder. Archives of Pediatric & Adolescent Medicine, 159, 572-578.
24. McNeal, R. E., Roberts, M. C., & Barone, V. J. (2000). Mothers' and children's perceptions of medication for children with attention-deficit hyperactivity disorder. Child Psychiatry & Human Development, 30, 173-187.
25. Meaux, J. B., Hester, C., Smith, B., & Shoptaw, A. (2006). Stimulant medications: A trade-off? The lived experience of adolescents with ADHD. Journal for Specialists in Pediatric Nursing, 11, 214-226.
26. Minkoff, N. B. (2009). ADHD in managed care: An assessment of the burden of illness and proposed initiatives to improve outcomes. American Journal of Managed Care, 15(Suppl. 5), 151-159.
27. Moline, S., & Frankenberger, W. (2001). Use of stimulant medication for treatment of attention deficit/hyperactivity disorder: A survey of middle and high school students' attitudes. Psychology in the Schools, 38, 569-584.
28. Pliszka, S. R. (2007). Pharmacologic treatment of attention-deficit/hyperactivity disorder: Efficacy, safety and mechanisms of action. Neuropsychology Review, 17, 61-72.
29. Powers, R. L., Marks, D. J., Miller, C. J., Newcorn, J. H., & Halperin, J. M. (2008). Stimulant treatment in children with attention-deficit/hyperactivity disorder moderates adolescent academic outcome. Journal of Child and Adolescent Psychopharmacology, 18, 449-459.
30. Prasad, V., Brogan, B., Mulvaney, C., Grainge, M., Stanton, W., & Sayal, K. (2013). How effective are drug treatments for children with ADHD at improving on-task behaviour and academic achievement in the school classroom? A systematic review and meta-analysis. European Child & Adolescent Psychiatry, 22, 203-216.
31. Singh, I. (2008). Beyond polemics: Science and ethics of ADHD. Nature Reviews Neuroscience, 9, 957-964.
32. Smith, J. A., Flowers, J., & Larkin, M. (2009). Interpretative phenomenological analysis: Theory, method and research. London, United Kingdom: Sage.
33. Smith, J. A., & Osborn, M. (2003). Interpretative phenomenological analysis. In J. A. Smith (Ed.), Qualitative psychology: A practical guide to research methods (pp. 51-80). London, United Kingdom: Sage.
34. Swanson, J. M., Baler, R. D., & Volkow, N. D. (2011). Understanding the effects of stimulant medications on cognition in individuals with attention-deficit hyperactivity disorder: A decade of progress. Neuropsychopharmacology Reviews, 36, 207-226.
35. Taylor, E., Dopfner, M., Sergeant, J., Asherson, P., Banaschewski, T., Buitelaar, J., Zuddas, A. (2004). European clinical guidelines for hyperkinetic disorder-First upgrade. European Child & Adolescent Psychiatry, 13(1), 17-30.
36. Travell, C., & Visser, J. (2006). "ADHD does bad stuffto you": Young people's and parents' experiences and perceptions of attention deficit hyperactivity disorder (ADHD). Emotional and Behavioural Difficulties, 11, 205-216.
37. Vinker, S., Vinker, R., & Elhayany, A. (2006). Prevalence of methylphenidate use among Israeli children. Clinical Drug Investigation, 26(3), 161-167.
38. Wilens, T. E., McBurnett, K., Bukstein, O., McGough, J., Greenhill, L., & Lerner, M. (2006). Multisite controlled study of OROS methylphenidate in the treatment of adolescents with attention deficit/hyperactivity disorder. Archives of Pediatrics & Adolescent Medicine, 160, 82-90.
39. Wolraich, M. L., Greenhill, L. L., Pelham, W., Swanson, J., Wilens, T., Palumbo, D., & August, G. (2001). Randomized, controlled trial of oros methylphenidate once a day in children with attention-deficit/hyperactivity disorder. Pediatrics, 108, 883-892.
40. Young, S., Bramham, J., Gray, K., & Rose, E. (2008). The experience of receiving a diagnosis and treatment of ADHD in adulthood. A qualitative study of clinically referred patients using interpretative phenomenological analysis. Journal of Attention Disorders, 11(4), 493-503.
41. Zuvekas, S. H., & Vitiello, B. (2012). Stimulant medication use among U.S. children: A twelve-year perspective. American Journal of Psychiatry, 169, 160-166.